![Daniel S. Chao](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel S. Chao
Corporate Officer/Principal at
RubrYc Therapeutics, Inc.
Profile
Daniel S.
Chao is the founder.
He founded Halo Neuro, Inc. in 2013, where he served as the Chief Executive Officer & Director until 2020.
He also founded RubrYc Therapeutics, Inc. in 2021 and currently holds the position of Chief Business Officer.
In his former positions, Dr. Chao was the Chief Executive Officer & Director of Herophilus, Inc. from 2020 to 2021, and a Board of Advisor at The Brigham & Women's Hospital, Inc. from 2018 to 2020.
Dr. Chao received his undergraduate degree from the University of California, Berkeley and his graduate degree from Stanford University School of Medicine.
Daniel S. Chao active positions
| Companies | Position | Start |
|---|---|---|
RubrYc Therapeutics, Inc.
 RubrYc Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies | Corporate Officer/Principal | 01/07/2021 |
Palo Santo Inc
 Palo Santo Inc Investment ManagersFinance Palo Santo invests in companies located in the United States. The firm targets companies operating in the fields of therapeutic application of psychedelics. It provides financing for seed, early and growth stage capital requirements. | Private Equity Investor | - |
Former positions of Daniel S. Chao
| Companies | Position | End |
|---|---|---|
Herophilus, Inc.
 Herophilus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurotherapeutics to cure complex brain diseases | Chief Executive Officer | 01/05/2021 |
Halo Neuro, Inc.
 Halo Neuro, Inc. Packaged SoftwareTechnology Services Develops neuroscience based technology | Founder | 01/11/2020 |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Director/Board Member | 01/11/2020 |
Training of Daniel S. Chao
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
15
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Halo Neuro, Inc.
Halo Neuro, Inc. Packaged SoftwareTechnology Services Develops neuroscience based technology | Technology Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RubrYc Therapeutics, Inc.
RubrYc Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic antibodies | Health Technology |
Herophilus, Inc.
Herophilus, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurotherapeutics to cure complex brain diseases | Health Technology |
Palo Santo Inc
Palo Santo Inc Investment ManagersFinance Palo Santo invests in companies located in the United States. The firm targets companies operating in the fields of therapeutic application of psychedelics. It provides financing for seed, early and growth stage capital requirements. | Finance |
- Stock Market
- Insiders
- Daniel S. Chao
